RUNX3 expression evaluation at protein level was performed on the same glioma samples applying Western blot (WB) analysis, and in a total 72 glioma specimens, among which 6 were astrocytoma grade I, 27 grade II, 17 grade III, and 22 grade IV (glioblastoma) were used (Table 1). Here, RUNX3 is linked to glioblastoma.